Scandal of the deadly diabetes drug subsidised by French state
Monday 27 December 2010
French politicians of both the right and left are facing severe embarrassment and legal recriminations with the forthcoming publication of an official report on what could become the worst health scandal in the country's history.
President Nicolas Sarkozy has promised "the most complete transparency" on how a drug which is now suspected to have killed up to 2,000 people was officially approved, and subsidised, for 33 years by the French health service.
Despite repeated warnings from scientists in France and abroad, the Mediator drug was prescribed to 5,000,000 French people, originally to fight diabetes and later as an appetite-suppressing, slimming pill. A report from the French health inspectorate, due in mid-January, will investigate why successive French health ministers, of the left and right, failed to heed advice that the drug – produced by the French pharmaceutical giant, Servier – was at best useless, and at worst highly dangerous.
Separate French press investigations have focused on an alleged campaign of intimidation and disinformation by the Servier company to keep the drug – and a lucrative predecessor, eventually banned in the US in 1997 – on the market.
Servier, the second largest French drugs company, founded 50 years ago by Jacques Servier, 88, a French doctor, is known for its cult of secrecy and its excellent relations with French politicians. President Sarkozy himself once worked for the company as a lawyer during his brief legal career, when he was a young man.
Mediator contains a substance called benfluorex, which has been alleged in a series of scientific investigations to attack the cardio-vascular system and, in particular, to damage the valves of the heart. Despite a series of warnings, the drug remained legal – and its use was even officially subsidised by the French health service – until late last year.
Approval was finally withdrawn after the publication of a study in April 2009 by a Breton lung specialist, Irène Frachon, which linked Mediator to scores of patients with otherwise unexplained heart valve problems. In November this year, the agency which runs the finances of the French health service calculated that the drug was responsible for at least 500 premature deaths. Another study, leaked to the newspaper Le Figaro, put the death toll at between 1,000 and 2,000.
The French Health Minister, Xavier Bertrand, has promised that the investigation will examine why a string of his predecessors failed to respond to warnings that Mediator was potentially dangerous. His predecessors include himself. In a previous stint in the job, in 2006, he decided to maintain the 65 per cent refund to patients who bought Mediator, despite an official report linking it to heart valve disease.
Other health ministers who have ignored previous reports criticising Mediator include, in 1999 and 1998, Martine Aubry, now leader of the main opposition party, the Parti Socialiste and Bernard Kouchner, the founder of Médécins sans Frontières. Both say they have no recollection of the warnings.
In a series of investigative articles, the newspaper Libération accused the Servier company, which emplys 20,000 people, of using "techniques of intimidation" to try to keep a cousin of Mediator, called Isoméride, on the lucrative US market in the 1990s. Researchers who criticised the drug recalled receiving anonymous threats, incuding parcels containing miniature coffins, but no direct link with Servier was established. The drug was banned in the US in 1997.
peopleContenders for Time magazine's Person of the Year are a mixture of the good, the bad and the holy
tvSteven Moffat reveals the actor was dying to take on the role of the Time Lord and says he is excited to see what he will do with the character
sportBayern Munich 2 Manchester City 3: City come from two down to beat reigning European Champions
newsAs the world remembers Mandela the hero, the prison where he spent 27 years seems all the more brutal
arts + ents... and a chance to paint Booker Prize winning author Hilary Mantel
danceUnder Tamara Rojo's inspired direction, it seems possible that it could challenge the dominance of the Royal Ballet. We meet some established names and rising stars
travelDiscover Uruguay's jet-set beach resort, an Atlantic enclave with plenty of art and culture to explore on the side
The ten coldest places on Earth
Sir Ian McKellen hits back at Damian Lewis' 'fruity actor' claims
Kenyan politician Mike Sonko left red-faced after photoshopping himself next to Nelson Mandela
Krokodil in Mexico? Teenager hospitalised after 'injecting drug into her genitals'
Nelson Mandela memorial: Cheers, jeers and a masterclass from Barack Obama that stole the show
- 1 It’s shameful that our universities have accepted gender segregation under pressure from the most oppressive religious fanatics
- 2 Sir Ian McKellen hits back at Damian Lewis' 'fruity actor' claims
- 3 Kenyan politician Mike Sonko left red-faced after photoshopping himself next to Nelson Mandela
- 4 Selfie at funeral: Cameron squeezes in on Obama snap at Mandela memorial
- 5 Is Facebook making us forget? Study shows that taking pictures ruin memories
- < Previous
- Next >
£50000 - £65000 per annum + BONUS + BENEFITS: Harrington Starr: A leading mark...
£60000 - £85000 per annum + BONUS + BENEFITS: Harrington Starr: A leading asse...
£22000 - £25000 per annum + Benefits: Harrington Starr: Junior/Grad C# .NET Wi...
Negotiable: Harrington Starr: C#.NET Developer (VB6,.NET, SQL, Winforms) Wokin...